Table:
Vaccination	Baseline peak time	Relative reduction of peak attack rate (%)	Relative reduction of epidemic size (%)
Country	15 Oc 30% cov	15 Oct 60% cov	15 Nov 30% cov	15 Nov 60% cov	15 Oct 30% cov	15 Oct 60% cov	15 Nov 30% cov	15 Nov 60% cov
US	(23 Sep–09 Nov)	(1–15)	(1–15)	(0–2)	(0–2)	(5–25)	(5–25)	(1–2)	(1–2)
UK	(10 Oct–19 Nov)	(1–29)	(1–29)	0	(0–1)	(11–30)	(11–31)	(1–4)	(1–4)
Canada	(04 Oct–14 Nov)	(1–21)	(1–21)	(0–1)	(0–1)	(10–30)	(10–32)	(1–5)	(1–5)
France	(11 Oct–21 Nov)	(2–32)	(2–32)	(0–2)	(0–2)	(12–32)	(12–33)	(1–5)	(1–5)
Italy	(17 Oct–23 Nov)	(5–38)	(5–38)	(0–1)	(0–1)	(13–35)	(13–36)	(1–5)	(1–5)
Spain	(09 Oct–19 Nov)	(1–30)	(1–30)	(0–1)	(0–1)	(11–32)	(11–33)	(1–4)	(1–4)
Germany	(11 Oct–20 Nov)	(2–34)	(2–34)	(0–1)	(0–1)	(12–33)	(12–34)	(1–4)	(1–4)

What are the following table content in markdown style: | Vaccination | Baseline peak time | <COLSPAN=4> Relative reduction of peak attack rate (%) | <COLSPAN=4> Relative reduction of epidemic size (%) | 
 | Country |  | 15 Oc 30% cov | 15 Oct 60% cov | 15 Nov 30%

cov | 15 Nov 60% cov | 15 Oct 30% cov | 15 Oct 60% cov | 15 Nov 30% cov | 15 Nov 60% cov | 
 | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | 
 | US | (23 Sep–09 Nov) | (1–15) | (1–15) | (0–2) | (0–2) | (5–25) | (5–25) | (1–2) | (1–2) | 
 | UK | (10 Oct–19 Nov) | (1–29) | (1–29) | 0 | (0–1) | (11–30) | (11–31) | (1–4) | (1–4) | 
 | Canada | (04 Oct–14 Nov) | (1–21) | (1–21) | (0–1) | (0–1) | (10–30) | (10–32) | (1–5) | (1–5) | 
 | France | (11 Oct–21 Nov) | (2–32) | (2–32) | (0–2) | (0–2) | (12–32) | (12–33) | (1–5) | (1–5) | 
 | Italy | (17 Oct–23 Nov) | (5–38) | (5–38) | (0–1) | (0–1) | (13–35) | (13–36) | (1–5) | (1–5) | 
 | Spain | (09 Oct–19 Nov) | (1–30) | (1–30) | (0–1) | (0–1) | (11–32) | (11–33) | (1–4) | (1–4) | 
 | Germany | (11 Oct–20 Nov) | (2–34) | (2–34) | (0–1) | (0–1) | (12–33) | (12–34) | (1–4) | (1–4) |